작성일 : 13-06-03
CH3 BioSystems
   http://ch3biosystems.com/index.php

CH3 BioSystems is a supplier of high-performance molecular tools and services for the discovery of protein methylation
pathways in cells and tissues.
 
Our flagship methylarginine-specific antibody, anti-mRG, is specifically designed to recognize the greatest number of
methylproteins currently known. The immunizing antigen is based on a site of methylation found in a minimally required
peptide sequence of consensus for arginine methylation. This tool provides a fundamental advantage for research that
is exploring the importance of protein methylation in biological systems.
 
Additional products now available for sale from our catalog and others in development are designed to promote simple
and rapid advance in the biomedical analysis of protein methylation.